Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Cardiology | Psychiatry | Journal

Back to Journal Articles

Depression Linked to Poor Outcomes for Cardiac Patients

Last Updated: January 19, 2011.

 

Worsening symptoms of depression associated with adverse outcomes in patients with heart failure

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Worsening symptoms of depression are associated with a poor prognosis in patients with heart failure, and routine assessment of these patients may help guide appropriate medical management, according to a study in the Jan. 25 issue of the Journal of the American College of Cardiology.

WEDNESDAY, Jan. 19 (HealthDay News) -- Worsening symptoms of depression are associated with a poor prognosis in patients with heart failure, and routine assessment of these patients may help guide appropriate medical management, according to a study in the Jan. 25 issue of the Journal of the American College of Cardiology.

Andrew Sherwood, Ph.D., from the Duke University Medical Center in Durham, N.C., and colleagues assessed 147 patients with heart failure with ejection fractions less than 40 percent for symptoms of depression. Depression was measured using the Beck Depression Inventory (BDI) at baseline and after one year. Patients were followed up for an average of five years.

The researchers found that a change in depressive symptoms over one year, as indicated by higher BDI scores, was associated with death or cardiovascular hospitalization. This result was true after controlling for baseline depression and other established risk factors, such as cause of heart failure, age, prior hospitalizations, and measures of heart-failure severity: ejection fraction and N-terminal pro-B-type natriuretic peptide level. Patients with the highest increase in depressive symptoms were at more than twice the risk of adverse outcomes compared to patients with minimal increases.

"It may be prudent for clinicians to reassess symptoms of depression routinely in heart failure patients to determine better appropriate medical management of these patients who are at increased risk for adverse clinical outcomes and impaired quality of life," the authors write.

One of the study authors disclosed financial relationships with the pharmaceutical and medical device industries.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.


Previous: Digital Ulcers Linked to More Severe Systemic Sclerosis Next: ASCO: Gene Test May Predict Colorectal Cancer Recurrence

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.